Circle Pharma, Inc.

Who: Boehringer Ingelheim and Circle Pharma What: The German pharma has entered in a research and licensing collaboration with Circle Pharma to develop a first-in-class cyclin inhibitor that could

Summer may be over, but the heat is rising in the world of biopharmaceutical financings with some big private and public company financings announced just after the 2 September Labor Day holiday, the

Venture capital investors have not taken the summer off, at least not during the first few weeks of June, continuing to support mega-rounds of $100m or more for biopharmaceutical companies with novel

Stock market volatility due to business interruptions caused by the novel coronavirus has brought most fundraising by public companies to a halt, but so far COVID-19 hasn’t slowed the flow of venture